Brown fat and semaglutide for weight loss
Treatments studied
Part of Hormones & metabolism clinical trials.
This study looks at how brown fat affects weight loss with the medication semaglutide (Wegovy). If you are starting semaglutide for obesity, this trial may help understand if it will work better for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 20 and 70 years old.
- You are about to start semaglutide (Wegovy) for weight loss.
- Your body mass index (BMI) is 27 or higher, and you have at least one weight-related health problem like high blood pressure, high cholesterol, fatty liver, sleep apnea, heart disease, or knee/hip arthritis. Or your BMI is 30 or higher.
- You do not have diabetes (type 1 or type 2).
- You have not had neck surgery or radiation to the neck.
- You are not pregnant or breastfeeding and have no conditions that prevent MRI scans (like a pacemaker).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how brown fat (a type of body fat) changes after starting semaglutide for weight loss. You may help researchers understand how this medication affects the body’s energy use, which could improve weight-loss treatments.
This study tests a medication called semaglutide (a once-weekly injection) to help people with obesity lose weight. It is for adults who have already tried lifestyle changes without success.
This study tests whether a medication called semaglutide (which helps with weight loss) can change the bacteria in your gut, which might play a role in weight regulation. By participating, you may receive a treatment that could help you lose weight while researchers learn more about how it works.
This study tests whether a low dose of semaglutide (a once-weekly injection) can help obese adults without diabetes lose weight. Semaglutide works by reducing appetite and helping your body use food differently.
This trial tests whether adding a plant-based supplement (called 20E) to the weight-loss medication semaglutide can improve weight loss and muscle health. You would take the supplement as capsules alongside your regular semaglutide treatment.
This study tests a nasal spray containing semaglutide (a GLP-1 receptor agonist) to see if it helps adults who are overweight or obese lose weight. It may be an option if you have a BMI between 27 and 35 and have not used other weight loss medications recently.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.